iRhythm Technologies Inc (IRTC) has experienced challenges in growth. The company operates in the Healthcare sector, specifically in the Medical Devices industry.
Over the past 4 years, iRhythm Technologies Inc has achieved a revenue compound annual growth rate (CAGR) of 65.5%, while earnings have grown at 26.8% CAGR.
Historical revenue and profitability trends for iRhythm Technologies Inc
The chart above illustrates iRhythm Technologies Inc's revenue trajectory over the past 4 years. The revenue pattern shows the challenges the company has faced in recent periods.
Annual percentage change in revenue and earnings
Growth rates provide insight into the momentum of iRhythm Technologies Inc's business.
How efficiently iRhythm Technologies Inc converts revenue into profit
Profit margins reveal how much of each dollar of revenue iRhythm Technologies Inc retains at different stages:
Analyst estimates and forward-looking indicators
Wall Street analysts project iRhythm Technologies Inc to continue growing earnings in the coming year. The consensus analyst rating is 4.6154 based on 13 analysts.
Based on our comprehensive analysis, iRhythm Technologies Inc (IRTC) demonstrates declining growth characteristics.
This growth analysis provides a comprehensive view of iRhythm Technologies Inc's historical performance and future outlook. Investors should consider these growth metrics alongside valuation, competitive positioning, and broader market conditions when making investment decisions. Past performance does not guarantee future results.
See how iRhythm Technologies Inc stacks up against similar companies
Explore growth analysis for top stocks
Related: IRTC Valuation, IRTC Dividend, IRTC Financial Health
Compare: IRTC vs AAPL, IRTC vs MSFT, IRTC vs GOOGL